Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aktiv Pharma Group
Broomfield, Colorado, United Statesaktivpharmagroup.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Other
01
Overview
Aktiv Pharma Group has a diversified pipeline of emergency-use autoinjectors (TXA, atropine, pralidoxime chloride, scopolamine, and combinations), with several programs in late-stage development supported by US government contracts, as well as partnered biologic combination products utilizing glass-free container technology. Clinical results are not published, but products are advancing toward commercialization, particularly for government and emergency markets.
- Therapeutic areas
- HematologyNeurologyOther
- Modalities
- Small moleculeBiologicDeviceDrug-device combination product
- Industry
- Biotech
02
Partnerships
Undisclosed leading biopharmaceutical company (for biologics + ARCH platform)US government (multiple contracts, including Department of Defense)
Beyond the preview
Go deeper on Aktiv Pharma Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aktiv Pharma Group.